The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma.
 
Revathi Kollipara
Employment - Fort Wayne Medical Oncology & Hematology (I); Phreesia (I)
Stock and Other Ownership Interests - Fort Wayne Medical Oncology & Hematology (I); Fort Wayne Orthopedics (I); Phreesia (I)
 
Griffin Budde
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Vasily N. Aushev
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Elise Kornreich Brunsgaard
No Relationships to Disclose
 
Timothy Kuzel
Honoraria - Amgen; Bristol Myers Squibb Foundation; Cardinal Health; CVS; eisai; Exelixis; Kyowa Kirin International; Merck; SeaGen; Tyme
Consulting or Advisory Role - enGene
Speakers' Bureau - Genomic Health; Sanofi Pasteur
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Seagen (Inst)
 
Cristina O'Donoghue
No Relationships to Disclose
 
Timothy Riddell
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Charuta C. Palsuledesai
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Michael Krainock
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Minetta C. Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Eisai (Inst); Exact Sciences (Inst); Genomic Health (Inst); GRAIL (Inst); Menarini Silicon Biosystems (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Genomic Health; GRAIL; Menarini Silicon Biosystems; Merck; Natera; Pfizer
 
Alan Tan
Stock and Other Ownership Interests - Adaptimmune; Aprea AB; Bluebird Bio; Editas Medicine; FATE Therapeutics; ImmunityBio; Iovance Biotherapeutics; MEI Pharma; natera
Honoraria - Bristol Myers Squibb Foundation; EMD Serono; Exelixis; Gilead Sciences; Merck; Myovant Sciences; natera
Consulting or Advisory Role - Exelixis; Foundation Medicine; Myovant Sciences
Speakers' Bureau - bristol myers squibb; EMD Serono; Exelixis; Gilead Sciences; Merck; natera